Everest Medicines Announces the Acceptance and Priority Review of VELSIPITY(R) Manufacturing Localization Application by the Center for Drug Evaluation of China’s NMPA, Driving Continued Commercial Momentum
Hong Kong, Oct 2, 2026 – (ACN Newswire) – Everest Medicines recently announced that the…